International Agency for Research on Cancer (IARC)

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. Its mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. 

International Agency for Research on Cancer (IARC) logo

UICC has collaborated with the Northern Ireland Cancer Registry (NICR) and the International Agency for Research on Cancer (IARC) to launch a supportive web-based staging tool for cancer registrars, CanStaging+, designed to maximise the availability of TNM staging rules in order to aid standardisation and comparability of cancer staging internationally.

UICC and IARC's working relationship

"IARC and UICC are sister organisations. UICC has been on the board of IARC since its inception, so it's natural for us to be doing activities and conferences together."
Dr Elisabete Weiderpass, Director of IARC at UICC's World Cancer Congress 2022

"Let's talk cancer" with Dr Elisabete Weiderpass: Obesity, nutrition and cancer

Dr Elisabete Weiderpass, Director of IARC, speaks to Dr Cary Adams, CEO of UICC, about public health actions that can address obesity by supporting healthier lifestyles include education, advertising bans, and higher taxes on sugar and food labels.

Doctor and patient in a hospital in Mexico

The Global Initiative for Cancer Registry Development (GICR) is a multi-partner response to the disparity in robust cancer statistics across the globe, led by the International Agency for Research on Cancer (IARC) and Union for International Cancer Control (UICC).

An NICR, IARC and UICC collaboration.

TNM explanatory graph

Published by the Union for International Cancer Control, the TNM Classification of Malignant Tumours (TNM) is a globally recognised standard for classifying the extent of spread of cancer.

Latest news and blog articles

Podcast "Let's Talk Cancer": Understanding the latest global trends in cancer control

Crowd of people in a city
Read more

GLOBOCAN 2022: Latest global cancer data shows rising incidence and stark inequities

Crowd of people in a city
Read more

Aspartame classified as possible carcinogen but acceptable daily intake remains unchanged

Man pours artificial sweetener containing aspartame into his tea.
Read more

Launch of CanStaging+, a new digital tool to improve data collection for cancer

Hospital staff examining an x-ray
Read more

GLOBOCAN 2020: New Global Cancer Data

UICC's Let's Talk Cancer image
Read more

Global Cancer Data: GLOBOCAN 2018

Read more

Last update

Friday 03 May 2024

Share this page